Tafas v. Dudas et al

Filing 110

MOTION for Leave to File Brief as Amicus Curiae in Support of Plaintiffs' Anticipated Motions for Summary Judgment by Human Genome Sciences, Inc.. (Attachments: # 1 Proposed Order # 2 Amicus Brief)(Scully, Robert)

Tafas v. Dudas et al

Doc. 110

Case 1:07-cv-00846-JCC-TRJ

Document 110

Filed 12/19/2007

Page 1 of 6

UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA Alexandria Division TRIANTAFYLLOS TAFAS, Plaint iff, v. JON W. DUDAS, et al. Defedants. ) ) ) ) ) ) ) ) )

Civil Action No. 1:07cv846 (JCC/TRJ)

CONSOLIDATED WITH SMITHKLINE BEECHAM CORPORATION, et al., Plaint iffs, v. JON W. DUDAS, in his official capacity as, Under-Secretary of Co mmerce for Intellectual Property and Director of the United States Patent and Trademark Office, et al., Defendants. ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

Civil Action No. 1:07cv1008 (JCC/TRJ)

MOTION OF AMICUS CURIAE HUMAN GENOME SCIENCES, INC. FOR LEAVE TO FILE ITS BRIEF IN SUPPORT OF THE "GSK" PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT Human Genome Sciences, Inc. ("HGS"), by undersigned counsel, moves for leave to file its brief as amicus curiae in support of plaintiffs Smithkline Beecham Corporation, Smithkline Beecham PLC and Glaxo Group Limited's Motions for Summary Judgment. HGS is a small biopharmaceutical company dedicated to discovery, development, manufacture and marketing of innovat ive drug products for patients with unmet medical needs

1
Dockets.Justia.com

Case 1:07-cv-00846-JCC-TRJ

Document 110

Filed 12/19/2007

Page 2 of 6

including lupus, hepatitis C and anthrax. Since its founding in 1992 over 500 patents have been issued to HGS. Currently HGS has more than 200 patent applications pending at the USPTO. Unlike GSK, HGS has not yet introduced any products into the market. HGS wishes to submit a brief addressing how the retroactive impact of the new Rules will adversely impact small innovative companies like HGS who are trying to maximize their as yet un-recouped capital investment in cutting edge biopharmaceutical innovations by consolidating patent applications. Pursuant to this Court's Order of December 5, 2007, HGS respectfully requests leave of this Court to file the enclosed Amicus Brief explaining the especially dramatic impact the retroactive application of the new rules would have on HGS and similar small biopharmaceutical companies. HGS believes its special situation provides it with a unique perspective that will be useful to the Court in adjudicating the parties' cross motions for summary judgment. HGS is authorized to state that GSK Plaintiffs and Mr. Tafas have consented to the filing of this brief. Additionally, The United States Patent and Trademark Office takes no position in response to the filing of this brief. Accompanying this Motion is a proposed order granting HGS leave to file the enclosed Amicus Brief. WHEREFORE, for good cause shown, Human Genome Sciences, Inc. requests that the Court grant leave to file the attached Amicus Brief and deem the brief filed as of the date of this motion without need to refile. Dated: This 19th day of December, 2007. Respectfully Submitted, /s/ Robert E. Scully Jr. VA Bar No. 19218 Counsel for Amicus Curiae Human Geno me Sciences, Inc. STITES & HARBISON PLLC

2

Case 1:07-cv-00846-JCC-TRJ

Document 110

Filed 12/19/2007

Page 3 of 6

1199 North Fairfax Street, Suite 900 Alexandria, Virginia 22314 [phone] Fax: [phone] rscully@st ites.com James H. Davis, Ph.D., J.D. Executive Vice President General Counsel Michele M. Wales, Ph.D., J.D. Vice President of Intellectual Property Jared S. Cohen, Ph.D., J.D. Patent Attorney Human Genome Sciences, Inc. 14200 Shady Grove Road Rockville, MD 20850

3

Case 1:07-cv-00846-JCC-TRJ

Document 110

Filed 12/19/2007

Page 4 of 6

CERTIFICATE OF SERVICE I hereby certify that on this 19th day of December 2007, the foregoing pleading was filed electronically using the CM/ECF system, which will send notification by electronic means to the following counsel of record: Joseph D. Wilson, Esq. Kelley Drye & Warren LLP 3050 K. Street, NW, Suite 400 Washington, D.C. 20007-5108 Email: [e-mail] Attorney for Plaintiff in Case No. 1:07cv846 Elizabeth M. Locke, Esq. Kirkland & Ellis LLP 655 15th Street, NW, Suite 1200 Washington, D.C. 20005 Email: [e-mail] and Craig C. Reilly, Esq. Richard McGettigan Reilly & West PC 1725 Duke Street, Suite 600 Alexandria, Virginia 22314 Email: [e-mail] Attorneys for Plaintiffs in Case No. 1:07cv1008 Chuck Rosenberg, Esq. United States Attorney Lauren A. Wetzler, Esq. R. Joseph Sher, Esq. Andrew Price, Esq. Assistant United States Attorneys United States Attorney's Office 2100 Jamison Avenue Alexandria, Virginia 22314 Email: [e-mail] Attorneys for Defendants in Case Nos. 1:07cv846 and 1:07cv1008

4

Case 1:07-cv-00846-JCC-TRJ

Document 110

Filed 12/19/2007

Page 5 of 6

Rebecca Malkin Carr, Esq. Pillsbury Wint hrop Shaw Pittman LLP 2300 N. Street, NW Washington, D.C. 20037 Email: [e-mail] and Scott J. Pivnick, Esq. Pillsbury Wint hrop Shaw Pittman LLP 1650 Tysons Boulevard McLean, Virginia 22102-4856 Email: [e-mail] Attorneys for Amicus Elan Pharmaceuticals, Inc. James Murphy Dowd, Esq. Wilmer Cutler Pickering Hale & Dorr, LLP 1455 Pennsylvania Avenue, NW Washington, D.C. 20004 Email: [e-mail] Attorney for Amicus Pharmaceutical Research and Manufacturers of America Dawn-Marie Bey, Esq. Kirkpatrick Stockton LLP 700 13th Street, NW, Suite 800 Washington, D.C. 20005 Email: [e-mail] Attorney for Amicus Hexas, LLC, The Roskamp Institute and Tikvah Therapeutics, Inc. Randall Karl Miller, Esq. Arno ld & Porter, LLP 1600 Tysons Boulevard, Suite 900 McLean, Virginia 22102 Email: [e-mail] Attorney for Amicus Biotechnology Industry Organization and Amicus Monsanto Company Charles Gorenstin, Esq. Birch, Stewart, Kolasch and Birch, LLP 8110 Gatehouse Road, Suite 100 East Falls Church, Virginia 22042 email: [e-mail] Attorney for Amicus Intellectual Property Institute Williams Mitchell College of Law

5

Case 1:07-cv-00846-JCC-TRJ

Document 110

Filed 12/19/2007

Page 6 of 6

Thomas J. O'Brien, Esq. Morgan Lewis & Blockius LLP 1111 Pennsylvania Avenue, NW Washington, D.C. 20004 Email: to'[e-mail] Attorney for Amicus American Intellectual Property Law Association /s/ Robert E. Scully Jr. VA Bar No. 19218 Counsel for Amicus Curiae Human Geno me Sciences, Inc. STITES & HARBISON PLLC 1199 North Fairfax Street, Suite 900 Alexandria, Virginia 22314 [phone] Fax: [phone] rscully@st ites.com

6